Blueprint Medicines Corporation (BPMC) by event type

BPMC moves most on coverage initiations — a median of -1.34% at 30 minutes across 20 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the BPMC overview →

By event type

How BPMC reacts across 5 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
2,322 of 2,717
15-0.42%27%-0.94%
Analyst downgrades
1,653 of 2,603
27-0.09%26%-0.16%
Coverage initiations
2,163 of 2,283
20-1.34%20%-2.37%
Rating reiterations
2,514 of 3,522
102-0.09%43%-0.52%
Price-target raises
1,113 of 1,790
24-0.04%46%-0.77%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.

That’s how BPMC usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · BPMC overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
SPRING BANK PHARMACEUTICALS (SBPH)4040.00%37%
AKCEA THERAPEUTICS (AKCA)4010.00%49%
EDGE THERAPEUTICS (EDGE)401-0.05%41%
Esperion Therapeutics, Inc. (ESPR)4010.00%47%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.